PAVmed (PAVM) Debt to Equity (2017 - 2025)
PAVmed's quarterly Debt to Equity came in at $0.5 in Q4 2025, up 104.27% year-on-year from $0.24 in Q4 2024, and up 134.6% quarter-over-quarter from $0.21 in Q3 2025.
PAVmed has reported Debt to Equity for 8 years, with the latest figure at $0.5 in Q4 2025.
- For the quarter ending Q4 2025, Debt to Equity rose 104.27% year-over-year to $0.5; the trailing twelve-month figure through Dec 2025 stood at $0.5 (up 104.27% YoY), and the FY2025 full-year result was $0.5, up 104.27% from the prior year.
- Debt to Equity for Q4 2025 stood at $0.5, up from $0.21 in the prior quarter.
- The five-year high for Debt to Equity was $4.1 in Q1 2023, with the low at -$11.66 in Q4 2024.
- Average Debt to Equity over 4 years is -$0.66, with a median of $0.21 recorded in 2025.
- Year-over-year, Debt to Equity slumped 653.47% in 2024 and soared 110.23% in 2025.
- Tracing PAVM's Debt to Equity over 4 years: stood at $3.08 in 2022, then plunged by 159.8% to -$1.84 in 2023, then tumbled by 533.78% to -$11.66 in 2024, then jumped by 104.27% to $0.5 in 2025.
- The last three Debt to Equity figures came in at $0.5 (Q4 2025), $0.21 (Q3 2025), and $0.24 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | 0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.50 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | 0.24 |
| Mar 31, 2025 | 0.17 |
| Dec 31, 2024 | -11.66 |
| Sep 10, 2024 | 1.12 |
| Jun 30, 2024 | -2.36 |
| Mar 31, 2024 | -2.21 |
| Dec 31, 2023 | -1.84 |
| Sep 30, 2023 | -2.84 |
| Jun 30, 2023 | -0.31 |
| Mar 31, 2023 | 4.10 |
| Dec 31, 2022 | 3.08 |
| Sep 30, 2022 | 1.24 |
| Jun 30, 2022 | 0.71 |
| Dec 31, 2020 | -9.73 |
| Sep 30, 2020 | -1.06 |
| Jun 30, 2020 | -0.97 |
| Mar 31, 2020 | -1.27 |
| Dec 31, 2019 | -3.51 |
| Sep 30, 2019 | -1.86 |
| Jun 30, 2019 | -3.61 |
| Mar 31, 2019 | -1.46 |
| Dec 31, 2018 | -3.19 |
| Sep 30, 2018 | 0.91 |
| Jun 30, 2018 | 0.42 |
| Mar 31, 2018 | 9.08 |
| Dec 31, 2017 | -0.68 |
| Sep 30, 2017 | -0.27 |